Diffusion-Weighted Magnetic Resonance Imaging for Assessing Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Carcinoma

Introduction: Locally advanced rectal carcinoma is commonly treated with neoadjuvant chemoradiotherapy (NCRT); however, accurate assessment of treatment response remains challenging because fibrosis, oedema, necrosis, and residual tumour may have overlapping imaging appearances.This study evaluated the role of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurements as quantitative imaging parameters for assessing response to NCRT.Materials and methods: This prospective observational study was conducted at Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, from June 2024 to December 2025.A total of 24 patients with biopsy-proven rectal adenocarcinoma underwent MRI before NCRT and repeat MRI six to eight weeks after completion of treatment, before surgery.Tumour volume, ADC, mesorectal fascia (MRF) involvement, extramural vascular invasion (EMVI), lymph-node involvement, and histopathological tumour regression grade were assessed.Histopathological tumour regression was graded using the Dworak tumour regression grading system.Results: Mean tumour volume decreased significantly from 41.24 ± 18.26 cm³ before NCRT to 2.17 ± 0.73 cm³ after treatment (p < 0.001).MRF involvement decreased from 14 (58.3%) to five (20.8%),EMVI from 11 (45.8%) to two (8.3%), and lymph-node involvement from 20 (83.3%) to six (25.0%).Post-treatment ADC was significantly higher in good responders than in poor responders (1.63 ± 0.10 vs. 0.94 ± 0.15 × 10⁻³ mm²/s; p < 0.001).The percentage change in ADC was also significantly greater in good responders (91.70 ± 20.27% vs. 10.87 ± 18.76%; p < 0.001).A post-NCRT ADC cutoff of >1.20 × 10⁻³ mm²/s demonstrated 94.7% sensitivity, 100.0%specificity, and an area under the curve (AUC) of 0.989.TRG1 was the most frequent histopathological regression grade, observed in 12 (50.0%)patients, followed by TRG2 in 10 (41.7%).Conclusion: DWI and ADC measurements provide useful quantitative information for assessing treatment response in locally advanced rectal carcinoma following NCRT.Post-treatment ADC and percentage change in ADC demonstrated high discriminatory performance within the study cohort, suggesting their potential role in non-invasive response assessment and preoperative planning.The observed reductions in tumour volume, MRF involvement, EMVI, and lymph-node involvement further support the value of integrating morphological and diffusion-based MRI parameters.However, the small sample size and limited distribution across some tumour regression categories warrant cautious interpretation.The identified ADC cutoff should be considered exploratory rather than an established clinical threshold.Larger multicentre studies with standardized imaging protocols, formal assessment of interobserver agreement, and longer follow-up are warranted to validate these findings and determine their clinical utility.

Authors

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119642
Primary Topic
MRI in cancer diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diffusion-Weighted Magnetic Resonance Imaging for Assessing Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Carcinoma

Doddamani Diwakar, Mounika Malreddygari, Swara B S, Suresh A
Cureus
MRI in cancer diagnosis
article

Diffusion-Weighted Magnetic Resonance Imaging for Assessing Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Carcinoma

Doddamani Diwakar, Mounika Malreddygari, Swara B S, Suresh A
article en

Abstract

Introduction: Locally advanced rectal carcinoma is commonly treated with neoadjuvant chemoradiotherapy (NCRT); however, accurate assessment of treatment response remains challenging because fibrosis, oedema, necrosis, and residual tumour may have overlapping imaging appearances.This study evaluated the role of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurements as quantitative imaging parameters for assessing response to NCRT.Materials and methods: This prospective observational study was conducted at Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, from June 2024 to December 2025.A total of 24 patients with biopsy-proven rectal adenocarcinoma underwent MRI before NCRT and repeat MRI six to eight weeks after completion of treatment, before surgery.Tumour volume, ADC, mesorectal fascia (MRF) involvement, extramural vascular invasion (EMVI), lymph-node involvement, and histopathological tumour regression grade were assessed.Histopathological tumour regression was graded using the Dworak tumour regression grading system.Results: Mean tumour volume decreased significantly from 41.24 ± 18.26 cm³ before NCRT to 2.17 ± 0.73 cm³ after treatment (p < 0.001).MRF involvement decreased from 14 (58.3%) to five (20.8%),EMVI from 11 (45.8%) to two (8.3%), and lymph-node involvement from 20 (83.3%) to six (25.0%).Post-treatment ADC was significantly higher in good responders than in poor responders (1.63 ± 0.10 vs. 0.94 ± 0.15 × 10⁻³ mm²/s; p < 0.001).The percentage change in ADC was also significantly greater in good responders (91.70 ± 20.27% vs. 10.87 ± 18.76%; p < 0.001).A post-NCRT ADC cutoff of >1.20 × 10⁻³ mm²/s demonstrated 94.7% sensitivity, 100.0%specificity, and an area under the curve (AUC) of 0.989.TRG1 was the most frequent histopathological regression grade, observed in 12 (50.0%)patients, followed by TRG2 in 10 (41.7%).Conclusion: DWI and ADC measurements provide useful quantitative information for assessing treatment response in locally advanced rectal carcinoma following NCRT.Post-treatment ADC and percentage change in ADC demonstrated high discriminatory performance within the study cohort, suggesting their potential role in non-invasive response assessment and preoperative planning.The observed reductions in tumour volume, MRF involvement, EMVI, and lymph-node involvement further support the value of integrating morphological and diffusion-based MRI parameters.However, the small sample size and limited distribution across some tumour regression categories warrant cautious interpretation.The identified ADC cutoff should be considered exploratory rather than an established clinical threshold.Larger multicentre studies with standardized imaging protocols, formal assessment of interobserver agreement, and longer follow-up are warranted to validate these findings and determine their clinical utility.

Cureus
MRI in cancer diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon